NASDAQ
Journey Medical Corporation (DERM) has a free cash flow growth of 145.75% as of Friday, May 29, 2026. This represents a 221.36% increase compared to its 12-month average of -120.09%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.